Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 28% ± 11% | |
microglial cell | 12 studies | 45% ± 17% | |
macrophage | 12 studies | 37% ± 18% | |
dendritic cell | 12 studies | 34% ± 13% | |
fibroblast | 10 studies | 26% ± 7% | |
classical monocyte | 9 studies | 21% ± 6% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
non-classical monocyte | 8 studies | 22% ± 6% | |
GABAergic neuron | 8 studies | 45% ± 25% | |
glutamatergic neuron | 8 studies | 49% ± 24% | |
myeloid cell | 8 studies | 26% ± 10% | |
monocyte | 8 studies | 30% ± 15% | |
smooth muscle cell | 7 studies | 28% ± 9% | |
adipocyte | 7 studies | 35% ± 10% | |
pericyte | 7 studies | 20% ± 3% | |
conventional dendritic cell | 6 studies | 28% ± 15% | |
interneuron | 6 studies | 45% ± 29% | |
astrocyte | 5 studies | 33% ± 14% | |
neuron | 4 studies | 28% ± 11% | |
granule cell | 4 studies | 23% ± 11% | |
natural killer cell | 4 studies | 18% ± 2% | |
cardiac muscle cell | 4 studies | 26% ± 4% | |
B cell | 4 studies | 20% ± 6% | |
type I pneumocyte | 4 studies | 19% ± 2% | |
oligodendrocyte | 4 studies | 29% ± 12% | |
mast cell | 4 studies | 24% ± 6% | |
plasmacytoid dendritic cell | 4 studies | 22% ± 5% | |
GABAergic interneuron | 3 studies | 32% ± 4% | |
mononuclear phagocyte | 3 studies | 23% ± 5% | |
epithelial cell | 3 studies | 21% ± 7% | |
Mueller cell | 3 studies | 22% ± 4% | |
retinal rod cell | 3 studies | 21% ± 3% | |
alveolar macrophage | 3 studies | 37% ± 9% | |
capillary endothelial cell | 3 studies | 20% ± 1% | |
endothelial cell of lymphatic vessel | 3 studies | 24% ± 3% | |
lymphocyte | 3 studies | 23% ± 7% | |
mesothelial cell | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1919.32 | 1444 / 1445 | 100% | 14.22 | 183 / 183 |
breast | 100% | 2587.73 | 459 / 459 | 99% | 12.52 | 1104 / 1118 |
lung | 99% | 2671.32 | 575 / 578 | 98% | 10.19 | 1137 / 1155 |
prostate | 100% | 1310.13 | 244 / 245 | 97% | 6.59 | 489 / 502 |
thymus | 99% | 1346.32 | 647 / 653 | 97% | 6.20 | 587 / 605 |
intestine | 100% | 1793.70 | 966 / 966 | 95% | 9.43 | 503 / 527 |
uterus | 100% | 2297.64 | 170 / 170 | 94% | 11.19 | 433 / 459 |
adrenal gland | 98% | 1086.82 | 253 / 258 | 96% | 7.14 | 220 / 230 |
bladder | 100% | 2006.38 | 21 / 21 | 92% | 7.24 | 465 / 504 |
stomach | 93% | 1375.34 | 334 / 359 | 97% | 14.39 | 277 / 286 |
kidney | 91% | 868.37 | 81 / 89 | 97% | 9.42 | 872 / 901 |
skin | 100% | 2394.08 | 1807 / 1809 | 88% | 8.54 | 413 / 472 |
brain | 82% | 728.72 | 2164 / 2642 | 100% | 9.59 | 704 / 705 |
ovary | 100% | 2265.85 | 180 / 180 | 80% | 3.61 | 343 / 430 |
pancreas | 55% | 381.84 | 180 / 328 | 97% | 10.42 | 172 / 178 |
blood vessel | 100% | 7401.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.72 | 29 / 29 |
spleen | 100% | 2578.33 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 3052.64 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1387.36 | 792 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.03 | 44 / 45 |
liver | 35% | 230.51 | 78 / 226 | 57% | 2.61 | 230 / 406 |
peripheral blood | 90% | 2257.75 | 840 / 929 | 0% | 0 | 0 / 0 |
heart | 90% | 1302.61 | 774 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 2.71 | 46 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0030041 | Biological process | actin filament polymerization |
GO_0033194 | Biological process | response to hydroperoxide |
GO_0034050 | Biological process | symbiont-induced defense-related programmed cell death |
GO_0006955 | Biological process | immune response |
GO_0035166 | Biological process | post-embryonic hemopoiesis |
GO_0070671 | Biological process | response to interleukin-12 |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_1905539 | Biological process | regulation of postsynapse to nucleus signaling pathway |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0038156 | Biological process | interleukin-3-mediated signaling pathway |
GO_0045348 | Biological process | positive regulation of MHC class II biosynthetic process |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0038043 | Biological process | interleukin-5-mediated signaling pathway |
GO_2000273 | Biological process | positive regulation of signaling receptor activity |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_2000318 | Biological process | positive regulation of T-helper 17 type immune response |
GO_0007165 | Biological process | signal transduction |
GO_0060396 | Biological process | growth hormone receptor signaling pathway |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0060333 | Biological process | type II interferon-mediated signaling pathway |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0043687 | Biological process | post-translational protein modification |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0043392 | Biological process | negative regulation of DNA binding |
GO_0035722 | Biological process | interleukin-12-mediated signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0008631 | Biological process | intrinsic apoptotic signaling pathway in response to oxidative stress |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0038157 | Biological process | granulocyte-macrophage colony-stimulating factor signaling pathway |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0022408 | Biological process | negative regulation of cell-cell adhesion |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0070757 | Biological process | interleukin-35-mediated signaling pathway |
GO_0031103 | Biological process | axon regeneration |
GO_0051770 | Biological process | positive regulation of nitric-oxide synthase biosynthetic process |
GO_0036016 | Biological process | cellular response to interleukin-3 |
GO_0001774 | Biological process | microglial cell activation |
GO_0060397 | Biological process | growth hormone receptor signaling pathway via JAK-STAT |
GO_0031959 | Biological process | nuclear receptor-mediated mineralocorticoid signaling pathway |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_1904037 | Biological process | positive regulation of epithelial cell apoptotic process |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0061180 | Biological process | mammary gland epithelium development |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_1902728 | Biological process | positive regulation of growth factor dependent skeletal muscle satellite cell proliferation |
GO_0046677 | Biological process | response to antibiotic |
GO_0010572 | Biological process | positive regulation of platelet activation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0070665 | Biological process | positive regulation of leukocyte proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0060399 | Biological process | positive regulation of growth hormone receptor signaling pathway |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0007498 | Biological process | mesoderm development |
GO_0042976 | Biological process | activation of Janus kinase activity |
GO_0014075 | Biological process | response to amine |
GO_0007260 | Biological process | tyrosine phosphorylation of STAT protein |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0045428 | Biological process | regulation of nitric oxide biosynthetic process |
GO_0032819 | Biological process | positive regulation of natural killer cell proliferation |
GO_0038065 | Biological process | collagen-activated signaling pathway |
GO_0007167 | Biological process | enzyme-linked receptor protein signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0006338 | Biological process | chromatin remodeling |
GO_0048008 | Biological process | platelet-derived growth factor receptor signaling pathway |
GO_0002250 | Biological process | adaptive immune response |
GO_0098586 | Biological process | cellular response to virus |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0070102 | Biological process | interleukin-6-mediated signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0051142 | Biological process | positive regulation of NK T cell proliferation |
GO_0030154 | Biological process | cell differentiation |
GO_1901731 | Biological process | positive regulation of platelet aggregation |
GO_0006915 | Biological process | apoptotic process |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0097296 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0046425 | Biological process | regulation of receptor signaling pathway via JAK-STAT |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005856 | Cellular component | cytoskeleton |
GO_0045121 | Cellular component | membrane raft |
GO_0031234 | Cellular component | extrinsic component of cytoplasmic side of plasma membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0031904 | Cellular component | endosome lumen |
GO_0005634 | Cellular component | nucleus |
GO_0019897 | Cellular component | extrinsic component of plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030526 | Cellular component | granulocyte macrophage colony-stimulating factor receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0000791 | Cellular component | euchromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005901 | Cellular component | caveola |
GO_0072536 | Cellular component | interleukin-23 receptor complex |
GO_0042022 | Cellular component | interleukin-12 receptor complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0043548 | Molecular function | phosphatidylinositol 3-kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0005131 | Molecular function | growth hormone receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0031702 | Molecular function | type 1 angiotensin receptor binding |
GO_0042393 | Molecular function | histone binding |
GO_0035401 | Molecular function | histone H3Y41 kinase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0051428 | Molecular function | peptide hormone receptor binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0043560 | Molecular function | insulin receptor substrate binding |
GO_0020037 | Molecular function | heme binding |
GO_0033130 | Molecular function | acetylcholine receptor binding |
GO_0005143 | Molecular function | interleukin-12 receptor binding |
Gene name | JAK2 |
Protein name | Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) Tyrosine-protein kinase (EC 2.7.10.2) Janus kinase 2 Janus kinase |
Synonyms | |
Description | FUNCTION: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins . Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins . Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, cell stimulation with erythropoietin (EPO) during erythropoiesis leads to JAK2 autophosphorylation, activation, and its association with erythropoietin receptor (EPOR) that becomes phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or STAT5B) is recruited, phosphorylated and activated by JAK2. Once activated, dimerized STAT5 translocates into the nucleus and promotes the transcription of several essential genes involved in the modulation of erythropoiesis. Part of a signaling cascade that is activated by increased cellular retinol and that leads to the activation of STAT5 (STAT5A or STAT5B) . In addition, JAK2 mediates angiotensin-2-induced ARHGEF1 phosphorylation . Plays a role in cell cycle by phosphorylating CDKN1B . Cooperates with TEC through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin . . |
Accessions | A0A1B0GVR5 A9QVL8 A0A1B0GTR9 O60674 Q506Q0 ENST00000636127.1 ENST00000476574.5 Q52R86 Q8IXP2 ENST00000381652.4 |